SE408301B - Sett att framtella 1-substituerade pyrazoloner -(5) - Google Patents

Sett att framtella 1-substituerade pyrazoloner -(5)

Info

Publication number
SE408301B
SE408301B SE7405078A SE7405078A SE408301B SE 408301 B SE408301 B SE 408301B SE 7405078 A SE7405078 A SE 7405078A SE 7405078 A SE7405078 A SE 7405078A SE 408301 B SE408301 B SE 408301B
Authority
SE
Sweden
Prior art keywords
methyl
group
pyrazolone
carbon atoms
acid
Prior art date
Application number
SE7405078A
Other languages
English (en)
Swedish (sv)
Inventor
E Moller
K Meng
E Wehinger
H Horstmann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2319280A external-priority patent/DE2319280A1/de
Priority claimed from DE2363139A external-priority patent/DE2363139A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SE408301B publication Critical patent/SE408301B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • C07D231/24—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms having sulfone or sulfonic acid radicals in the molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
    • C07D231/52—Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Catalysts (AREA)
SE7405078A 1973-04-17 1974-04-16 Sett att framtella 1-substituerade pyrazoloner -(5) SE408301B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2319280A DE2319280A1 (de) 1973-04-17 1973-04-17 1-substituierte pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2363139A DE2363139A1 (de) 1973-12-19 1973-12-19 1-substituierte pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
SE408301B true SE408301B (sv) 1979-06-05

Family

ID=25764996

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7405078A SE408301B (sv) 1973-04-17 1974-04-16 Sett att framtella 1-substituerade pyrazoloner -(5)

Country Status (27)

Country Link
US (1) US3957814A (fr)
JP (1) JPS5314071B2 (fr)
AR (5) AR207444A1 (fr)
AT (1) AT337176B (fr)
BG (5) BG21405A3 (fr)
CA (1) CA1034953A (fr)
CH (5) CH605797A5 (fr)
DD (1) DD113757A5 (fr)
DK (1) DK136066C (fr)
EG (1) EG11157A (fr)
ES (3) ES425373A1 (fr)
FI (1) FI57587C (fr)
FR (1) FR2226172B1 (fr)
GB (1) GB1429141A (fr)
HK (1) HK70276A (fr)
HU (1) HU168590B (fr)
IE (1) IE39212B1 (fr)
IL (1) IL44626A (fr)
LU (1) LU69872A1 (fr)
NL (1) NL177917C (fr)
NO (1) NO138530C (fr)
PH (1) PH14829A (fr)
PL (1) PL96883B1 (fr)
RO (2) RO69740A (fr)
SE (1) SE408301B (fr)
SU (2) SU539525A3 (fr)
YU (1) YU104874A (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056533A (en) * 1973-04-17 1977-11-01 Bayer Aktiengesellschaft Pyrazol-5-ones
DE2526467A1 (de) * 1975-06-13 1976-12-30 Bayer Ag 4-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3306366A1 (de) * 1983-02-24 1984-08-30 Bayer Ag, 5090 Leverkusen Muzolimin enthaltende arzneimittel, deren verwendung und verfahren zu deren herstellung
US4663327A (en) * 1984-05-23 1987-05-05 Bayer Aktiengesellschaft 1-heteroaryl-4-aryl-pyrazolin-5-ones
JPH0730031B2 (ja) * 1986-04-02 1995-04-05 日産化学工業株式会社 ２―ピラゾリン―５―オン類の製造法
DE3738963A1 (de) * 1987-11-17 1989-05-24 Bayer Ag 3-aminopyrazolin-5-one
US5711929A (en) * 1989-05-06 1998-01-27 698638 Alberta Ltd. Purification of elemental sulphur
GB8912861D0 (en) * 1989-06-05 1989-07-26 Sherritt Gordon Ltd Purification of elemental sulphur
JPH079410Y2 (ja) * 1989-05-08 1995-03-06 株式会社アンレット 炭酸ガスレーザー光線発振器用ルーツブロワー
US5399565A (en) * 1990-07-17 1995-03-21 Eli Lilly And Company Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations therof
US5300514A (en) * 1990-07-17 1994-04-05 Eli Lilly And Company Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof
EP0478195B1 (fr) * 1990-09-21 1999-05-26 Rohm And Haas Company Dihydropyridazinones et pyridazinones comme fongicides
CN1038249C (zh) * 1991-08-28 1998-05-06 罗姆和哈斯公司 含有二氢哒嗪酮及其相关化合物的杀菌组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2376380A (en) * 1945-05-22 Preparation of amino pyrazolones
GB636988A (en) * 1947-12-24 1950-05-10 Gevaert Photo Producten Naamlo Improvements in and relating to the production of colour photographic images
US2511231A (en) * 1949-03-26 1950-06-13 Eastman Kodak Co 1-cyanophenyl-3-acylamino-5-pyrazolone couplers for color photography
US2600788A (en) * 1949-06-07 1952-06-17 Eastman Kodak Co Halogen-substituted pyrazolone couplers for color photography
US2672417A (en) * 1949-12-31 1954-03-16 Gevaert Photo Prod Nv Production of color photographic images
NL279140A (fr) * 1961-05-31

Also Published As

Publication number Publication date
CH605797A5 (fr) 1978-10-13
AR207444A1 (es) 1976-10-08
FI57587C (fi) 1980-09-10
LU69872A1 (fr) 1974-11-28
AR205272A1 (es) 1976-04-21
FR2226172B1 (fr) 1978-07-28
IL44626A (en) 1980-01-31
FI57587B (fi) 1980-05-30
BG21857A3 (fr) 1976-09-20
PL96883B1 (pl) 1978-01-31
NO138530C (no) 1978-09-20
US3957814A (en) 1976-05-18
IE39212L (en) 1974-10-17
HU168590B (fr) 1976-06-28
AT337176B (de) 1977-06-10
ATA313274A (de) 1976-10-15
JPS5314071B2 (fr) 1978-05-15
HK70276A (en) 1976-11-19
BG21218A3 (fr) 1976-03-20
NL7405115A (fr) 1974-10-21
NL177917C (nl) 1985-12-16
RO63749A (fr) 1979-01-15
DK136066B (da) 1977-08-08
ES447063A1 (es) 1977-06-16
CA1034953A (fr) 1978-07-18
AR208192A1 (es) 1976-12-09
DK136066C (da) 1978-01-16
IL44626A0 (en) 1974-06-30
BG22821A3 (fr) 1977-04-20
AR204951A1 (es) 1976-03-19
BG21405A3 (fr) 1976-05-20
NO741365L (no) 1974-10-18
CH596172A5 (fr) 1978-02-28
CH603592A5 (fr) 1978-08-31
BG21217A3 (fr) 1976-03-20
EG11157A (en) 1978-03-29
GB1429141A (en) 1976-03-24
YU104874A (en) 1982-02-28
FR2226172A1 (fr) 1974-11-15
JPS5018466A (fr) 1975-02-26
DD113757A5 (fr) 1975-06-20
AR205271A1 (es) 1976-04-21
SU539525A3 (ru) 1976-12-15
CH605800A5 (fr) 1978-10-13
AU6817474A (en) 1975-10-23
IE39212B1 (en) 1978-08-30
PH14829A (en) 1981-12-16
SU541430A3 (ru) 1976-12-30
NO138530B (no) 1978-05-12
ES447064A1 (es) 1977-09-16
CH605801A5 (fr) 1978-10-13
NL177917B (nl) 1985-07-16
ES425373A1 (es) 1976-09-01
RO69740A (fr) 1982-09-09

Similar Documents

Publication Publication Date Title
EP1713475B1 (fr) Derives de 4,5-dihydro-1h-pyrazole 1,3,5-trisubstitues presentant une activite antagonistique a cb1
JP4495257B2 (ja) Ｎｏｓ抑制剤としてのｎ−複素環誘導体
EP1725536B1 (fr) Derives de l'imidazoline presentant une activite antagoniste cb1
AU777735B2 (en) Bradykinin B1 receptor antagonists
SE408301B (sv) Sett att framtella 1-substituerade pyrazoloner -(5)
JPH07324076A (ja) 新規なピラゾール−３−カルボキサミド誘導体、これらを製造するための方法及びこれらが存在する薬学的組成物
US7745476B2 (en) 1,3,5-trisubstituted 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
KR19990063989A (ko) 염증 치료용의 1,3,5-삼치환된 피라졸 화합물
CA2408408C (fr) Modulateurs de marquage du tnf-alpha
US4288446A (en) Pyrazol-5-ones
DE1946370B2 (de) Substituierte Pyrazol-4-essigsauren, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
FR2537584A1 (fr) Pyrazoloquinoleines substituees particulieres, procede pour leur preparation, preparations pharmaceutiques contenant ces composes et leur application therapeutique
PL93398B1 (fr)
US3250761A (en) New sulfonamides
HU201015B (en) Process for producing pyridine derivatives
US3962453A (en) Novel pyrazolyloxyacetic acid derivatives and process for the preparation thereof
CA1048513A (fr) Pyrazol-5-ones
HUT52038A (en) Process for producing alpha-cyano-beta-oxo-propion-amides
US3365447A (en) 2, 5-dihydro-4-hydroxy-2-oxothiophens
US4207317A (en) 1-Aryl-4-carbamoyl-pyrazolin-5-ones
US4000294A (en) Pyrazol-5-ones
US4081596A (en) Pyrazol-5-ones
US4038410A (en) Nitroimidazole derivatives and process for the preparation thereof
WO2000018741A2 (fr) Nouveaux composes
DE2526467A1 (de) 4-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7405078-2

Effective date: 19900411

Format of ref document f/p: F